125 related articles for article (PubMed ID: 2683987)
1. Adjuvant FAM2 in resectable gastric cancer.
Lise M; Nitti D; Buyse M; Marchet A; Fiorentino M; Dos Santos JG; Duez N
Anticancer Res; 1989; 9(4):1017-21. PubMed ID: 2683987
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of gastric cancer: a review.
Kelsen D
Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
4. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS
Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959
[No Abstract] [Full Text] [Related]
5. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
[No Abstract] [Full Text] [Related]
6. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
Repetto L; Campora E; Nobile MT; Rosso R
G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
[No Abstract] [Full Text] [Related]
8. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
[TBL] [Abstract][Full Text] [Related]
9. [Present status of surgical adjuvant chemotherapy of gastric cancer].
Taguchi T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2169-72. PubMed ID: 2500066
[TBL] [Abstract][Full Text] [Related]
10. No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Chen S; Chen YB; Zhou ZW; Li W; Sun XW; Xu DZ; Li YF; Guan YX; Feng XY; Zhan YQ
Am J Clin Oncol; 2011 Jun; 34(3):309-13. PubMed ID: 20838324
[TBL] [Abstract][Full Text] [Related]
11. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study].
Jakesz R; Dittrich C; Funovics J; Hofbauer F; Rainer H; Reiner G; Schemper M; Schiessel R; Starlinger M
Wien Klin Wochenschr; 1986 Dec; 98(24):824-30. PubMed ID: 3103336
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
Hagin GD; Jain A
Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
[TBL] [Abstract][Full Text] [Related]
14. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant chemotherapy in advanced stomach cancer].
Zehner J; Weber L; Fischer M; Gfirtner H; Breit A
Med Klin (Munich); 1986 Jun; 81(13):445-8. PubMed ID: 3785030
[No Abstract] [Full Text] [Related]
16. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
[TBL] [Abstract][Full Text] [Related]
17. [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
Hara K; Yokoyama T; Furuta K; Shinoda M; Yajima K; Yasuda S; Nakazaki S; Kiyomitsu Y; Watanabe K
Gan No Rinsho; 1984 Apr; 30(4):399-402. PubMed ID: 6727041
[TBL] [Abstract][Full Text] [Related]
18. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
